Spontaneous metastasis in mouse models of testicular germ-cell tumours

International Journal of Andrology

Volumn 34, Issue 4 PART 2, 2011, Pages

  Zechel, J L ^a   Maclennan, G T ^b   Heaney, J D ^a   Nadeau, J H ^a  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

Metastasis; Mouse model; Testicular cancer

Indexed keywords

OCTAMER TRANSCRIPTION FACTOR 4; STAGE SPECIFIC EMBRYO ANTIGEN 1; X LINKED INHIBITOR OF APOPTOSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHROMOSOME 12; CHROMOSOME 17; CHROMOSOME 5; COPY NUMBER VARIATION; ECTOPIC STEM CELL; EMBRYONIC STEM CELL; FEMALE; GENOTYPE; GERM CELL TUMOR; INGUINAL LYMPH NODE; LIVER METASTASIS; LYMPH NODE METASTASIS; MALE; METASTASIS; MOUSE; NONHUMAN; PANCREAS METASTASIS; PERITONEUM METASTASIS; PRIORITY JOURNAL; SPLEEN METASTASIS; STEM CELL; TESTIS CANCER;

ANIMALS; ANTIGENS, CD15; DISEASE MODELS, ANIMAL; DNA COPY NUMBER VARIATIONS; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; GERM CELLS; MALE; MICE; NEOPLASM METASTASIS; NEOPLASMS, GERM CELL AND EMBRYONAL; OCTAMER TRANSCRIPTION FACTOR-3; POLYMERASE CHAIN REACTION; TESTICULAR NEOPLASMS;

EID: 79960867215     PISSN: 01056263     EISSN: 13652605     Source Type: Journal    
DOI: 10.1111/j.1365-2605.2011.01160.x     Document Type: Article

References (65)

1. Akbarian S, Smith MA & Jones EG. (1995) Editing for an AMPA receptor subunit RNA in prefrontal cortex and striatum in Alzheimer's disease, Huntington's disease and schizophrenia. Brain Res 699, 297-304.
2. Anant S & Davidson NO. (2001) Molecular mechanisms of apolipoprotein B mRNA editing. Curr Opin Lipidol 12, 159-165.
3. Anderson R, Copeland TK, Scholer H, Heasman J & Wylie C. (2000) The onset of germ cell migration in the mouse embryo. Mech Dev 91, 61-68.
4. Angulo JC, Gonzalez J, Rodriguez N, Hernandez E, Nunez C, Rodriguez-Barbero JM et al. (2009) Clinicopathological study of regressed testicular tumors (apparent extragonadal germ cell neoplasms). J Urol 182, 2303-2310.
5. Benne R, Van den BJ, Brakenhoff JP, Sloof P, Van Boom JH & Tromp MC. (1986) Major transcript of the frameshifted coxII gene from trypanosome mitochondria contains four nucleotides that are not encoded in the DNA. Cell 46, 819-826.
6. Bosl GJ & Motzer RJ. (1997) Testicular germ-cell cancer. N Engl J Med 337, 242-253.
7. Braude I, Vukovic B, Prasad M, Marrano P, Turley S, Barber D et al. (2006) Large scale copy number variation (CNV) at 14q12 is associated with the presence of genomic abnormalities in neoplasia. BMC Genomics 7, 138.
8. Brydoy M, Fossa SD, Klepp O, Bremnes RM, Wist EA, Wentzel-Larsen T & Dahl O. (2005) Paternity following treatment for testicular cancer. J Natl Cancer Inst 97, 1580-1588.
9. Cheng L. (2004) Establishing a germ cell origin for metastatic tumors using OCT4 immunohistochemistry. Cancer 101, 2006-2010.
10. Cheng L, Sung MT, Cossu-Rocca P, Jones TD, MacLennan GT, De JJ et al. (2007) OCT4: biological functions and clinical applications as a marker of germ cell neoplasia. J Pathol 211, 1-9.
11. Clark AT, Rodriguez RT, Bodnar MS, Abeyta MJ, Cedars MI, Turek PJ et al. (2004) Human STELLAR, NANOG, and GDF3 genes are expressed in pluripotent cells and map to chromosome 12p13, a hotspot for teratocarcinoma. Stem Cells 22, 169-179.
12. De Giorgi U, Nicolai N, Tana S, Tavolini IM, Palazzi S, Bracarda S et al. (2008) IGG practice guidelines on germ cell tumor in adult male patients. Tumori 94, 96-109.
13. Di Cristofano A, Pesce B, Cordon-Cardo C & Pandolfi PP. (1998) Pten is essential for embryonic development and tumour suppression. Nat Genet 19, 348-355.
14. Di PA, Vries EG, Gietema JA, Spierings DC & de JS. (2005) Testicular germ cell tumours: the paradigm of chemo-sensitive solid tumours. Int J Biochem Cell Biol 37, 2437-2456.
15. Disibio G & French SW. (2008) Metastatic patterns of cancers: results from a large autopsy study. Arch Pathol Lab Med 132, 931-939.
16. Dixon FJ & Moore RA. (1953) Testicular tumors; a clinicopathological study. Cancer 6, 427-454.
17. Fabre E, Jira H, Izard V, Ferlicot S, Hammoudi Y, Theodore C et al. (2004) 'Burned-out' primary testicular cancer. BJU Int 94, 74-78.
18. Fenderson BA, Andrews PW, Nudelman E, Clausen H & Hakomori S. (1987) Glycolipid core structure switching from globo- to lacto- and ganglio-series during retinoic acid-induced differentiation of TERA-2-derived human embryonal carcinoma cells. Dev Biol 122, 21-34.
19. Fine G, Smith RW Jr & Pachter MR. (1962) Primary extragenital choriocarcinoma in the male subject. Case report and review of the literature. Am J Med 32, 776-794.
20. Fossa SD, Kaye SB, Mead GM, Cullen M, de WR, Bodrogi I et al. (1998) Filgrastim during combination chemotherapy of patients with poor-prognosis metastatic germ cell malignancy. European Organization for Research and Treatment of Cancer, Genito-Urinary Group, and the Medical Research Council Testicular Cancer Working Party, Cambridge, United Kingdom. J Clin Oncol 16, 716-724.
21. Hailemariam S, Engeler DS, Bannwart F & Amin MB. (1997) Primary mediastinal germ cell tumor with intratubular germ cell neoplasia of the testis-further support for germ cell origin of these tumors: a case report. Cancer 79, 1031-1036.
22. Heaney JD & Nadeau JH. (2008) Testicular germ cell tumors in mice: new ways to study a genetically complex trait. Methods Mol Biol 450, 211-231.
23. Hill-Baskin AE, Markiewski MM, Buchner DA, Shao H, DeSantis D, Hsiao G et al. (2009) Diet-induced hepatocellular carcinoma in genetically predisposed mice. Hum Mol Genet 18, 2975-2988.
24. Holzik MF, Sijmons RH, Hoestra-Weebers J, Sleijfer DT & Hoekstra HJ. (2008) Clinical and genetic aspects of testicular germ cell tumours. Hered Cancer Clin Pract 6, 3-14.
25. Huddart RA & Norman A. (2003) Changes in BMI after treatment of testicular cancer are due to age and hormonal function and not chemotherapy. Br J Cancer 89, 1143-1144.
26. Huddart RA, Norman A, Shahidi M, Horwich A, Coward D, Nicholls J & Dearnaley DP. (2003) Cardiovascular disease as a long-term complication of treatment for testicular cancer. J Clin Oncol 21, 1513-1523.
27. Johnson DE, Laneri JP, Mountain CF & Luna M. (1973) Extragonadal germ cell tumors. Surgery 73, 85-90.
28. Jones TD, Ulbright TM, Eble JN, Baldridge LA & Cheng L. (2004) OCT4 staining in testicular tumors: a sensitive and specific marker for seminoma and embryonal carcinoma. Am J Surg Pathol 28, 935-940.
29. Kimura T, Suzuki A, Fujita Y, Yomogida K, Lomeli H, Asada N, Ikeuchi M, Nagy A, Mak TW & Nakano T. (2003) Conditional loss of PTEN leads to testicular teratoma and enhances embryonic germ cell production. Development 130, 1691-1700.
30. Korkola JE, Heck S, Olshen AB, Reuter VE, Bosl GJ, Houldsworth J & Chaganti RS. (2008) In vivo differentiation and genomic evolution in adult male germ cell tumors. Genes Chromosom Cancer 47, 43-55.
31. Lam MY, Youngren KK & Nadeau JH. (2004) Enhancers and suppressors of testicular cancer susceptibility in single- and double-mutant mice. Genetics 166, 925-933.
32. Loehrer PJ Sr, Gonin R, Nichols CR, Weathers T & Einhorn LH. (1998) Vinblastine plus ifosfamide plus cisplatin as initial salvage therapy in recurrent germ cell tumor. J Clin Oncol 16, 2500-2504.
33. Looijenga LH, Stoop H, de Leeuw HP, de Gouveia Brazao CA, Gillis AJ, van Roozendaal KE et al. (2003) POU5F1 (OCT3/4) identifies cells with pluripotent potential in human germ cell tumors. Cancer Res 63, 2244-2250.
34. MacLean G, Li H, Metzger D, Chambon P & Petkovich M. (2007) Apoptotic extinction of germ cells in testes of Cyp26b1 knockout mice. Endocrinology 148, 4560-4567.
35. Maris C, Dominguez C & Allain FH. (2005) The RNA recognition motif, a plastic RNA-binding platform to regulate post-transcriptional gene expression. FEBS J 272, 2118-2131.
36. Matin A, Collin GB, Asada Y, Varnum D & Nadeau JH. (1999) Susceptibility to testicular germ-cell tumours in a 129.MOLF-Chr 19 chromosome substitution strain. Nat Genet 23, 237-240.
37. Matsumoto T, Marusawa H, Endo Y, Ueda Y, Matsumoto Y & Chiba T. (2006) Expression of APOBEC2 is transcriptionally regulated by NF-kappaB in human hepatocytes. FEBS Lett 580, 731-735.
38. Molyneaux KA, Stallock J, Schaible K & Wylie C. (2001) Time-lapse analysis of living mouse germ cell migration. Dev Biol 240, 488-498.
39. Mueller T, Mueller LP, Holzhausen HJ, Witthuhn R, Albers P & Schmoll HJ. (2010) Histological evidence for the existence of germ cell tumor cells showing embryonal carcinoma morphology but lacking OCT4 expression and cisplatin sensitivity. Histochem Cell Biol 134, 197-204.
40. Niwa H, Miyazaki J & Smith AG. (2000) Quantitative expression of Oct-3/4 defines differentiation, dedifferentiation or self-renewal of ES cells. Nat Genet 24, 372-376.
41. Noguchi T & Stevens LC. (1982) Primordial germ cell proliferation in fetal testes in mouse strains with high and low incidences of congenital testicular teratomas. J Natl Cancer Inst 69, 907-913.
42. Okamoto K, Okazawa H, Okuda A, Sakai M, Muramatsu M & Hamada H. (1990) A novel octamer binding transcription factor is differentially expressed in mouse embryonic cells. Cell 60, 461-472.
43. Piulats JM, Jimenez L, Garcia d, Villanueva A, Vinals F & Germa-Lluch JR. (2009) Molecular mechanisms behind the resistance of cisplatin in germ cell tumours. Clin Transl Oncol 11, 780-786.
44. Powles TB, Bhardwa J, Shamash J, Mandalia S & Oliver T. (2005) The changing presentation of germ cell tumours of the testis between 1983 and 2002. BJU Int 95, 1197-1200.
45. Richie JP & Steele GS. (2007) Neoplasms of the testis. In: Campbell-Walsh Urology (eds AJ Wein, LR Kavoussi, AC Novick, AW Partin & CA Peters), pp. 893-935. Saunders Elsevier, Philadelphia.
46. Rodriguez E, Mathew S, Reuter V, Ilson DH, Bosl GJ & Chaganti RS. (1992) Cytogenetic analysis of 124 prospectively ascertained male germ cell tumors. Cancer Res 52, 2285-2291.
47. Rosenstraus MJ. (1983) Isolation and characterization of an embryonal carcinoma cell line lacking SSEA-1 antigen. Dev Biol 99, 318-323.
48. Rosner MH, Vigano MA, Ozato K, Timmons PM, Poirier F, Rigby PW & Staudt LM. (1990) A POU-domain transcription factor in early stem cells and germ cells of the mammalian embryo. Nature 345, 686-692.
49. Runyan C, Schaible K, Molyneaux K, Wang Z, Levin L & Wylie C. (2006) Steel factor controls midline cell death of primordial germ cells and is essential for their normal proliferation and migration. Development 133, 4861-4869.
50. Shi M, Liu D, Duan H, Shen B & Guo N. (2010) Metastasis-related miRNAs, active players in breast cancer invasion, and metastasis. Cancer Metastasis Rev 29, 785-799.
51. Skotheim RI, Autio R, Lind GE, Kraggerud SM, Andrews PW, Monni O et al. (2006) Novel genomic aberrations in testicular germ cell tumors by array-CGH, and associated gene expression changes. Cell Oncol 28, 315-326.
52. Solter D & Knowles BB. (1978) Monoclonal antibody defining a stage-specific mouse embryonic antigen (SSEA-1). Proc Natl Acad Sci USA 75, 5565-5569.
53. Stevens LC. (1962a) Testicular teratomas in fetal mice. J Natl Cancer Inst 28, 247-267.
54. Stevens LC. (1962b) The biology of teratomas including evidence indicating their origin form primordial germ cells. Annee Biol 1, 585-610.
55. Stevens LC. (1967) Origin of testicular teratomas from primordial germ cells in mice. J Natl Cancer Inst 38, 549-552.
56. Stevens LC. (1973) A new inbred subline of mice (129-terSv) with a high incidence of spontaneous congenital testicular teratomas. J Natl Cancer Inst 50, 235-242.
57. Stevens LC & Hummel KP. (1957) A description of spontaneous congenital testicular teratomas in strain 129 mice. J Natl Cancer Inst 18, 719-747.
58. Travis LB, Fossa SD, Schonfeld SJ, McMaster ML, Lynch CF, Storm H et al. (2005) Second cancers among 40, 576 testicular cancer patients: focus on long-term survivors. J Natl Cancer Inst 97, 1354-1365.
59. Ulbright TM. (1999) Testis risk and prognostic factors. The pathologist's perspective. Urol Clin North Am 26, 611-626.
60. Upadhyay S & Zamboni L. (1982) Ectopic germ cells: natural model for the study of germ cell sexual differentiation. Proc Natl Acad Sci USA 79, 6584-6588.
61. Williams SD, Birch R, Einhorn LH, Irwin L, Greco FA & Loehrer PJ. (1987) Treatment of disseminated germ-cell tumors with cisplatin, bleomycin, and either vinblastine or etoposide. N Engl J Med 316, 1435-1440.
62. Wolff EM, Chihara Y, Pan F, Weisenberger DJ, Siegmund KD, Sugano K et al. (2010) Unique DNA methylation patterns distinguish noninvasive and invasive urothelial cancers and establish an epigenetic field defect in premalignant tissue. Cancer Res 70, 8169-8178.
63. Yang H, Zhang C, Zhao X, Wu Q, Fu X, Yu B et al. (2010) Analysis of copy number variations of BS69 in multiple types of hematological malignancies. Ann Hematol 89, 959-964.
64. Youngren KK, Coveney D, Peng X, Bhattacharya C, Schmidt LS, Nickerson ML et al. (2005) The Ter mutation in the dead end gene causes germ cell loss and testicular germ cell tumours. Nature 435, 360-364.
65. Zamboni L & Upadhyay S. (1983) Germ cell differentiation in mouse adrenal glands. J Exp Zool 228, 173-193.